“We will Appraise how the commercialization of this compound fits in with our organization product at Adastra in order to situation ourselves to guidance the desire for a secure offer of copyright,” mentioned Main executive officer Michael Forbes inside of a news launch. The corporate told VICE Information it would not be commenting even more.�